1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Smoking Significantly Impacts Persistence Rates in Embolized Pulmonary Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia

      research-article
      , MD, , MD, , MS, , MD, , MD
      Radiology
      Radiological Society of North America

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Embolization is the standard of care for treatment of pulmonary arteriovenous malformations (PAVMs). Persistence of PAVMs after embolization occurs for undefined reasons but may include inflammation related to smoking in dysregulated angiogenesis.

          Purpose

          To determine whether patients with hereditary hemorrhagic telangiectasia (HHT) who smoke tobacco are more prone to PAVM persistence after embolization.

          Materials and Methods

          Patients with HHT treated for PAVMs between January 2000 and August 2017 were retrospectively identified. Only PAVMs with no previous treatment and patients with both clinical and imaging follow-up were included. Age, sex, PAVM characteristics (size, complexity, and location), embolization material used, microcatheter type, smoking history, active tobacco use, and other risk factors for arterial disease were analyzed by using a multivariate Cox proportional hazards model to determine risk factors for persistence.

          Results

          Five-year persistence-free survival rates in nonsmokers, smokers of 1–20 pack-years, and smokers of more than 20 pack-years were 12.2%, 21.9%, and 37.4% respectively. Smokers with more than 20 pack-years relative to nonsmokers had greater risk of persistence after adjusting for arterial feeder size (hazard ratio, 3.8; 95% confidence interval [CI]: 1.5, 10.0; P = .007). Patients who reported active tobacco use at the time of PAVM embolization had a 5-year cumulative incidence of persistence of 26.3% compared with 13.5% in inactive smokers. After adjusting for arterial feeder size, the risk of persistence was greater in tobacco users versus inactive smokers at the time of treatment (hazard ratio, 2.4; 95% CI: 1.2, 4.7; P = .01).

          Conclusion

          Smoking is associated with pulmonary arteriovenous malformation persistence after embolization in patients with hereditary hemorrhagic telangiectasia.

          Online supplemental material is available for this article.

          See also the editorial by Trerotola and Pyeritz in this issue.

          Abstract

          Related collections

          Most cited references31

          • Record: found
          • Abstract: found
          • Article: not found

          International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia.

          HHT is an autosomal dominant disease with an estimated prevalence of at least 1/5000 which can frequently be complicated by the presence of clinically significant arteriovenous malformations in the brain, lung, gastrointestinal tract and liver. HHT is under-diagnosed and families may be unaware of the available screening and treatment, leading to unnecessary stroke and life-threatening hemorrhage in children and adults. The goal of this international HHT guidelines process was to develop evidence-informed consensus guidelines regarding the diagnosis of HHT and the prevention of HHT-related complications and treatment of symptomatic disease. The overall guidelines process was developed using the AGREE framework, using a systematic search strategy and literature retrieval with incorporation of expert evidence in a structured consensus process where published literature was lacking. The Guidelines Working Group included experts (clinical and genetic) from eleven countries, in all aspects of HHT, guidelines methodologists, health care workers, health care administrators, HHT clinic staff, medical trainees, patient advocacy representatives and patients with HHT. The Working Group determined clinically relevant questions during the pre-conference process. The literature search was conducted using the OVID MEDLINE database, from 1966 to October 2006. The Working Group subsequently convened at the Guidelines Conference to partake in a structured consensus process using the evidence tables generated from the systematic searches. The outcome of the conference was the generation of 33 recommendations for the diagnosis and management of HHT, with at least 80% agreement amongst the expert panel for 30 of the 33 recommendations.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Society of Interventional Radiology Clinical Practice Guidelines

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Society of Interventional Radiology clinical practice guidelines.

                Bookmark

                Author and article information

                Contributors
                Journal
                Radiology
                Radiology
                Radiology
                Radiology
                Radiological Society of North America
                0033-8419
                1527-1315
                September 2019
                30 July 2019
                : 292
                : 3
                : 762-770
                Affiliations
                [1]From the Department of Radiology (M.M.H., E.C.B., S.M.), Department of Biomedical Statistics and Informatics (W.S.H.), and Department of Pulmonary and Critical Care Medicine (V.N.I.), Mayo Clinic, 200 First St SW, Rochester, MN 55905.
                Author notes
                Address correspondence to S.M. (e-mail: misra.sanjay@ 123456mayo.edu ).

                Author contributions: Guarantors of integrity of entire study, M.M.H., V.N.I., S.M.; study concepts/study design or data acquisition or data analysis/interpretation, all authors; manuscript drafting or manuscript revision for important intellectual content, all authors; approval of final version of submitted manuscript, all authors; agrees to ensure any questions related to the work are appropriately resolved, all authors; literature research, M.M.H., V.N.I., S.M.; clinical studies, V.N.I., S.M.; statistical analysis, M.M.H., W.S.H., S.M.; and manuscript editing, all authors

                Author information
                http://orcid.org/0000-0001-5662-796X
                Article
                180978
                10.1148/radiol.2019180978
                6735354
                31361208
                17fceb5c-404c-4d53-a53e-f2ad73b752a7
                2019 by the Radiological Society of North America, Inc.

                Published under a http://creativecommons.org/licenses/by/4.0/CC BY 4.0 license.

                History
                : 24 April 2018
                : 22 May 2018
                : 3 June 2019
                : 11 June 2019
                Funding
                Funded by: National Institutes of Health http://dx.doi.org/10.13039/100000002
                Award ID: DK 108780
                Award ID: HL098967
                Categories
                Original Research
                Vascular and Interventional Radiology
                VA, Vascular Radiology
                IR, Interventional Radiology

                Comments

                Comment on this article